Detalles de la búsqueda
1.
COVID-19 and myocardial infarction - Authors' reply.
Lancet
; 398(10315): 1964, 2021 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838176
2.
Risk of arrhythmias following COVID-19: nationwide self-controlled case series and matched cohort study.
Eur Heart J Open
; 3(6): oead120, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089855
3.
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.
Eur Urol
; 81(3): 285-293, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980495
4.
Spatial clustering and contextual factors associated with hospitalisation and deaths due to COVID-19 in Sweden: a geospatial nationwide ecological study.
BMJ Glob Health
; 6(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34321234
5.
Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients.
Eur Urol
; 81(6): e143-e144, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248411
6.
Patients with severe orthohantavirus cardiopulmonary syndrome due to Sin Nombre Virus infection have increased circulating extracellular vesicle tissue factor and an activated coagulation system.
Thromb Res
; 179: 31-33, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31075699
Resultados
1 -
6
de 6
1
Próxima >
>>